SCHEDULE: Deep Track Capital Discloses 9.99% Stake in Verastem

Deep Track Capital, LP and affiliated entities have reported a 9.99% beneficial ownership stake in Verastem, Inc. common stock.

Summary

• Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively beneficially own 7,719,390 shares of Verastem, Inc. common stock.
• This ownership represents 9.99% of Verastem, Inc.'s outstanding common stock.
• The reporting persons hold shared voting power and shared dispositive power over all 7,719,390 shares.
• The calculation of beneficial ownership is based on 75,292,640 common shares outstanding as of November 17, 2025, plus 1,978,540 common shares convertible by the reporting person up to the maximum percentage.
• The beneficially owned shares include 3,870,000 Pre-Funded Warrants exercisable into common shares, subject to a 9.99% maximum exercise limitation.
• The securities were not acquired or held for the purpose of changing or influencing control of Verastem, Inc., other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership and does not contain information that inherently suggests a positive or negative sentiment regarding the company's performance or outlook. It is a neutral, compliance-driven report.

Positives

• A significant institutional investor, Deep Track Capital, has disclosed a substantial 9.99% stake in Verastem, Inc., potentially signaling confidence in the company's long-term prospects.

Future Outlook

NA

Industry Context

The disclosure of a significant stake by a specialized biotechnology investment firm like Deep Track Capital in Verastem, Inc. is a routine event in the biotech sector, where institutional investors frequently take positions in companies with promising pipelines or strategic directions. This filing does not provide specific insights into broader industry trends but highlights continued institutional interest in the sector.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional holder like Deep Track Capital may be viewed positively, indicating investor confidence. The certification that the stake is not for control purposes provides clarity on the investor's intent.

Key Dates

Keywords

Verastem, Deep Track Capital, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Institutional Investor, Biotechnology